Coronavirus vaccines have progressed extraordinarily quickly in reaching the final stages of clinical testing, supporting the possibility that hundreds of millions of doses could be administered in 2021.
A vaccine is widely acknowledged as a crucial element in exiting this pandemic. But in order to truly help society, a vaccine needs to be safe, effective and widely available.
Business Insider’s healthcare reporter Andrew Dunn will discuss the road ahead for coronavirus vaccines on October 5th at 2:00 pm ET.
In this live webinar, Dunn will talk with three leading vaccine experts: Maria Elena Bottazzi, co-director of Texas Children’s Hospital Center for Vaccine Development and associate dean of Baylor College of Medicine’s National School of Tropical Medicine, Art Caplan, a bioethicist and founding head of the Division of Medical Ethics at New York University School of Medicine, and Dr. William Haseltine, infectious-disease expert and chair and president of ACCESS Health International.
The panel will discuss what it takes to get a vaccine candidate across the finish line and what happens after that. Even with a safe and effective vaccine, drugmakers and governments will need to collaborate on plans for mass-production, fairly distributing the shot, and convincing the public to get vaccinated. Leading experts will weigh in on the latest challenges and how they are being tackled.